INHIBIKASE THERAPEUTICS INC (IKT): Institutional Ownership
Hedge funds and institutional managers reporting a position in IKT · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$2.3M
Across holders
Last Price
$1.91
2026-06-26
Sector
Health Care
GICS
Holder activity5 new1 added0 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 848K | $1.4M | 62.2% | 0.0% | New | — | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 468K | $787K | 34.3% | 0.0% | Added | +$728K | Q1 2026 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 18K | $30K | 1.3% | 0.0% | New | — | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 17K | $28K | 1.2% | 0.0% | New | — | Q1 2026 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 10K | $23K | 1.0% | 0.0% | New | — | Q1 2025 |
| AQR CAPITAL MANAGEMENT LLC CIK 0001167557 | Hedge Fund | 56 | $94 | 0.0% | 0.0% | New | — | Q1 2026 |
New
Hedge Fund
$1.4M· 62.2% of total· 0.0% port· 848K sh· — QoQ· Q1 2026
Added
Hedge Fund
$787K· 34.3% of total· 0.0% port· 468K sh· +$728K QoQ· Q1 2026
New
Hedge Fund
$30K· 1.3% of total· 0.0% port· 18K sh· — QoQ· Q1 2026
New
Hedge Fund
$28K· 1.2% of total· 0.0% port· 17K sh· — QoQ· Q1 2026
New
Hedge Fund
$23K· 1.0% of total· 0.0% port· 10K sh· — QoQ· Q1 2025
New
Hedge Fund
$94· 0.0% of total· 0.0% port· 56 sh· — QoQ· Q1 2026